IBRNvsIDEV
iShares Neuroscience and Healthcare ETF against iShares Core MSCI International Developed Markets ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBRN | IDEV | |
|---|---|---|
| Expense ratio | 0.47% | 0.040% |
| Assets | $6554.32T | $31.9B |
| Net flow, 1 month | +$428 | +$614M |
| Net flow, 1 year | +$2M | +$6.6B |
| Return, YTD | +0.7% | +8.6% |
| Return, 1 year | +16.4% | +9.9% |
| Avg daily volume | 2K | 2.5M |
| Holdings | 54 | 2281 |
| Listed | Aug 24, 2022 | Mar 21, 2017 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS